Review on the worldwide regulatory framework for biosimilars focusing on the Mexican case as an emerging market in Latin America.

Abstract:

:The global biopharmaceutical market is worth over $100 billion USD. Nearly 90% of these products will lose their patent in the next ten years, leading to the commercialization of their subsequent versions, known as 'biosimilars'. Biosimilars are much more complex molecules than chemically synthesized generics in terms of size, structure, stability, microheterogeneity, manufacture, etc. Therefore, a specific regulatory framework is needed in order to demonstrate their comparability with innovative products, as well as their quality, safety and efficacy. The EU published the first regulatory pathway in 2005 and has approved 14 biosimilars. Mexico has recently developed a clear regulatory pathway for these products. Their legal basis was established in Article 222 Bis of General Law of Health in 2009, clear specifications in the Regulation for Health Goods in 2011, and further requirements in the Mexican Official Norm NOM-EM-001-SSA1-2012. The aim of this review is to summarize the regulatory pathways for biosimilars in the world with a special focus on Mexican experience, so as contribute to the development of regulations in other countries.

journal_name

Biotechnol Adv

journal_title

Biotechnology advances

authors

Ibarra-Cabrera R,Mena-Pérez SC,Bondani-Guasti A,García-Arrazola R

doi

10.1016/j.biotechadv.2013.05.005

subject

Has Abstract

pub_date

2013-12-01 00:00:00

pages

1333-43

issue

8

eissn

0734-9750

issn

1873-1899

pii

S0734-9750(13)00086-4

journal_volume

31

pub_type

杂志文章,评审
  • Can a late bloomer become an early bird? Tools for flowering time adjustment.

    abstract::The transition from the vegetative to reproductive stage followed by inflorescence is a critical step in plant life; therefore, studies of the genes that influence flowering time have always been of great interest to scientists. Flowering is a process controlled by many genes interacting mutually in a genetic network,...

    journal_title:Biotechnology advances

    pub_type: 杂志文章,评审

    doi:10.1016/j.biotechadv.2013.09.008

    authors: Milec Z,Valárik M,Bartoš J,Safář J

    更新日期:2014-01-01 00:00:00

  • Lipase immobilization on ceramic supports: An overview on techniques and materials.

    abstract::Enzyme immobilization is a well-known technique that allows the reuse of the biocatalyst and generally improves its stability. These improved characteristics are of fundamental importance to turn industrial biocatalysis into viable and competitive processes. The immobilization of enzymes can occur through several phys...

    journal_title:Biotechnology advances

    pub_type: 杂志文章,评审

    doi:10.1016/j.biotechadv.2020.107581

    authors: Mulinari J,Oliveira JV,Hotza D

    更新日期:2020-01-01 00:00:00

  • Generation and applications of monoclonal antibodies for livestock production.

    abstract::Monoclonal antibodies (MCAs) have found widespread applications in livestock production. Although the generation of murine MCAs is at present a routine, the production of homologous MCAs, especially important for in vivo applications, is still hampered by the lack of efficient homologous fusion partners for immortaliz...

    journal_title:Biotechnology advances

    pub_type: 杂志文章

    doi:10.1016/0734-9750(94)90291-7

    authors: Van Der Lende T

    更新日期:1994-01-01 00:00:00

  • Silver bullets: A new lustre on an old antimicrobial agent.

    abstract::Silver was widely used in medicine to treat bacterial infections in the 19th and early 20th century, up until the discovery and development of the first modern antibiotics in the 1940s, which were markedly more effective. Since then, every new antibiotic introduced to the clinic has led to an associated development of...

    journal_title:Biotechnology advances

    pub_type: 杂志文章,评审

    doi:10.1016/j.biotechadv.2018.05.004

    authors: Möhler JS,Sim W,Blaskovich MAT,Cooper MA,Ziora ZM

    更新日期:2018-01-01 00:00:00

  • RNAi therapeutic and its innovative biotechnological evolution.

    abstract::Recently, United States Food and Drug Administration (FDA) and European Commission (EC) approved Alnylam Pharmaceuticals' RNA interference (RNAi) therapeutic, ONPATTRO™ (Patisiran), for the treatment of the polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis in adults. This is the first RNAi therap...

    journal_title:Biotechnology advances

    pub_type: 杂志文章,评审

    doi:10.1016/j.biotechadv.2019.04.012

    authors: Weng Y,Xiao H,Zhang J,Liang XJ,Huang Y

    更新日期:2019-01-01 00:00:00

  • Implementing CRISPR-Cas technologies in conventional and non-conventional yeasts: Current state and future prospects.

    abstract::Within five years, the CRISPR-Cas system has emerged as the dominating tool for genome engineering, while also changing the speed and efficiency of metabolic engineering in conventional (Saccharomyces cerevisiae and Schizosaccharomyces pombe) and non-conventional (Yarrowia lipolytica, Pichia pastoris syn. Komagataella...

    journal_title:Biotechnology advances

    pub_type: 杂志文章,评审

    doi:10.1016/j.biotechadv.2018.01.006

    authors: Raschmanová H,Weninger A,Glieder A,Kovar K,Vogl T

    更新日期:2018-01-01 00:00:00

  • RNA-based technologies for insect control in plant production.

    abstract::RNA interference (RNAi) is a biological process in which small RNA (sRNA) molecules sequence-specifically silence gene expression at the transcriptional or post-transcriptional level, either by directing inhibitory chromatin modifications or by decreasing the stability or translation potential of the targeted mRNA. Th...

    journal_title:Biotechnology advances

    pub_type: 杂志文章,评审

    doi:10.1016/j.biotechadv.2019.107463

    authors: Liu S,Jaouannet M,Dempsey DA,Imani J,Coustau C,Kogel KH

    更新日期:2020-01-01 00:00:00

  • Process engineering for microbial production of 3-hydroxypropionic acid.

    abstract::Due to concerns about the unsustainability and predictable shortage of fossil feedstocks, research efforts are currently being made to develop new processes for production of commodities using alternative feedstocks. 3-Hydroxypropionic acid (CAS 503-66-2) was recognised by the US Department of Energy as one of the mos...

    journal_title:Biotechnology advances

    pub_type: 杂志文章,评审

    doi:10.1016/j.biotechadv.2018.03.020

    authors: de Fouchécour F,Sánchez-Castañeda AK,Saulou-Bérion C,Spinnler HÉ

    更新日期:2018-01-01 00:00:00

  • Development of thrombolytic agents.

    abstract::Despite their widespread use in patients with acute myocardial infarction, all currently available thrombolytic agents suffer from a number of significant limitations, including resistance to reperfusion, the occurrence of acute coronary reocclusion and bleeding complications. Furthermore, the therapeutic use of plasm...

    journal_title:Biotechnology advances

    pub_type: 杂志文章

    doi:10.1016/0734-9750(93)90411-f

    authors: Lijnen HR,Collen D

    更新日期:1993-01-01 00:00:00

  • Engineering of transcriptional regulators enhances microbial stress tolerance.

    abstract::Both prokaryotes and eukaryotes have pyramid-shaped hierarchical regulatory networks that control gene transcription, enabling the cell to respond to natural environmental changes. In recent years, manipulation and engineering of transcriptional regulatory proteins and networks have been used to elicit microbial toler...

    journal_title:Biotechnology advances

    pub_type: 杂志文章,评审

    doi:10.1016/j.biotechadv.2013.02.010

    authors: Lin Z,Zhang Y,Wang J

    更新日期:2013-11-01 00:00:00

  • Bio-synthesis of food additives and colorants-a growing trend in future food.

    abstract::Food additives and colorants are extensively used in the food industry to improve food quality and safety during processing, storage and packing. Sourcing of these molecules is predominately through three means: extraction from natural sources, chemical synthesis, and bio-production, with the first two being the most ...

    journal_title:Biotechnology advances

    pub_type: 杂志文章,评审

    doi:10.1016/j.biotechadv.2020.107694

    authors: Sun L,Xin F,Alper HS

    更新日期:2021-01-01 00:00:00

  • Operational parameters for packed beds in solid-state cultivation.

    abstract::Packed bed cultivation systems have potential for widespread application in solid-state cultivation (SSC), but they are poorly characterized. The effects of particle size and substrate loading on the growth of Rhizopus oligosporus on sago-beads in packed bed bioreactors were investigated. Pressure drop and protein wer...

    journal_title:Biotechnology advances

    pub_type: 杂志文章

    doi:10.1016/0734-9750(93)90029-m

    authors: Gumbira-Sa'id E,Greenfield PF,Mitchell DA,Doelle HW

    更新日期:1993-01-01 00:00:00

  • Artificial seeds.

    abstract::The use of somatic embryos as artificial seeds for large scale clonal propagation of plants is close to becoming a reality. The quality of the artificial seed depends on the temporal, quantitative and qualitative supply of growth regulator and nutrients along with an optimal physical environment. Desiccation of somati...

    journal_title:Biotechnology advances

    pub_type: 杂志文章

    doi:10.1016/0734-9750(92)90301-o

    authors: Senaratna T

    更新日期:1992-01-01 00:00:00

  • Cell-free protein synthesis systems.

    abstract::Cell-free protein synthesis systems enable the direct in vitro expression of proteins from template DNA or RNA. Use of biochemical and bioengineering techniques has greatly improved the yields and productivities of cell-free systems. In some cases, the yields approach the in vivo levels. Moreover, in vitro systems are...

    journal_title:Biotechnology advances

    pub_type: 杂志文章

    doi:10.1016/s0734-9750(97)00082-7

    authors: Nakano H,Yamane T

    更新日期:1998-03-01 00:00:00

  • Next-generation metabolic engineering approaches towards development of plant cell suspension cultures as specialized metabolite producing biofactories.

    abstract::Plant cell suspension culture (PCSC) has emerged as a viable technology to produce plant specialized metabolites (PSM). While Taxol® and ginsenoside are two examples of successfully commercialized PCSC-derived PSM, widespread utilization of the PCSC platform has yet to be realized primarily due to a lack of understand...

    journal_title:Biotechnology advances

    pub_type: 杂志文章,评审

    doi:10.1016/j.biotechadv.2020.107635

    authors: Arya SS,Rookes JE,Cahill DM,Lenka SK

    更新日期:2020-12-01 00:00:00

  • Design, preparation and application of nucleic acid delivery carriers.

    abstract::Gene delivery vectors must deliver their cargoes into the cytosol or the nucleus, where DNA or siRNA functions in vivo. Therefore it is crucial for the rational design of the nucleic acid delivery carriers. Compared with viral vectors, non-viral vectors have overcome some fatal defections in gene therapy. Whereas the ...

    journal_title:Biotechnology advances

    pub_type: 杂志文章,评审

    doi:10.1016/j.biotechadv.2013.11.004

    authors: Yang J,Liu H,Zhang X

    更新日期:2014-07-01 00:00:00

  • Gene therapy, gene targeting and induced pluripotent stem cells: applications in monogenic disease treatment.

    abstract::Monogenic diseases are often severe, life-threatening disorders for which lifelong palliative treatment is the only option. Over the last two decades, a number of strategies have been devised with the aim to treat these diseases with a genetic approach. Gene therapy has been under development for many years, yet suffe...

    journal_title:Biotechnology advances

    pub_type: 杂志文章

    doi:10.1016/j.biotechadv.2010.05.019

    authors: Wong GK,Chiu AT

    更新日期:2010-11-01 00:00:00

  • Polyamines: natural and engineered abiotic and biotic stress tolerance in plants.

    abstract::Polyamines (PAs) are ubiquitous biogenic amines that have been implicated in diverse cellular functions in widely distributed organisms. In plants, mutant and transgenic plants with altered activity pointed to their involvement with different abiotic and biotic stresses. Furthermore, microarray, transcriptomic and pro...

    journal_title:Biotechnology advances

    pub_type: 杂志文章,评审

    doi:10.1016/j.biotechadv.2011.01.003

    authors: Hussain SS,Ali M,Ahmad M,Siddique KH

    更新日期:2011-05-01 00:00:00

  • Enhancing stem cell survival in vivo for tissue repair.

    abstract::The ability to use progenitor cells for regenerative medicine remains an evolving but elusive clinical goal. A serious obstacle towards widespread use of stem cells for tissue regeneration is the challenges that face these cells when they are placed in vivo into a wound for therapy. These environments are hypoxic, aci...

    journal_title:Biotechnology advances

    pub_type: 杂志文章,评审

    doi:10.1016/j.biotechadv.2012.11.003

    authors: Hyun JS,Tran MC,Wong VW,Chung MT,Lo DD,Montoro DT,Wan DC,Longaker MT

    更新日期:2013-09-01 00:00:00

  • Can plant biotechnology help break the HIV-malaria link?

    abstract::The population of sub-Saharan Africa is at risk from multiple, poverty-related endemic diseases. HIV and malaria are the most prevalent, but they disproportionately affect different groups of people, i.e. HIV predominantly affects sexually-active adults whereas malaria has a greater impact on children and pregnant wom...

    journal_title:Biotechnology advances

    pub_type: 杂志文章,评审

    doi:10.1016/j.biotechadv.2014.02.004

    authors: Vamvaka E,Twyman RM,Christou P,Capell T

    更新日期:2014-05-01 00:00:00

  • Towards high-yield production of pharmaceutical proteins with plant cell suspension cultures.

    abstract::"Molecular farming" in plants with significant advantages in cost and safety is touted as a promising platform for the production of complex pharmaceutical proteins. While whole-plant produced biopharmaceuticals account for a significant portion of the preclinical and clinical pipeline, plant cell suspension culture, ...

    journal_title:Biotechnology advances

    pub_type: 杂志文章

    doi:10.1016/j.biotechadv.2011.01.002

    authors: Xu J,Ge X,Dolan MC

    更新日期:2011-05-01 00:00:00

  • Molecular targets for detection and immunotherapy in Cryptosporidium parvum.

    abstract::Cryptosporidium parvum is an obligate protozoan parasite responsible for the diarrheal illness cryptosporidiosis in humans and animals. Although C. parvum is particularly pathogenic in immunocompromised hosts, the molecular mechanisms by which C. parvum invades the host epithelial cells are not well understood. Charac...

    journal_title:Biotechnology advances

    pub_type: 杂志文章,评审

    doi:10.1016/j.biotechadv.2006.08.003

    authors: Boulter-Bitzer JI,Lee H,Trevors JT

    更新日期:2007-01-01 00:00:00

  • Enabling personalized implant and controllable biosystem development through 3D printing.

    abstract::The impact of additive manufacturing in our lives has been increasing constantly. One of the frontiers in this change is the medical devices. 3D printing technologies not only enable the personalization of implantable devices with respect to patient-specific anatomy, pathology and biomechanical properties but they als...

    journal_title:Biotechnology advances

    pub_type: 杂志文章,评审

    doi:10.1016/j.biotechadv.2018.02.004

    authors: Nagarajan N,Dupret-Bories A,Karabulut E,Zorlutuna P,Vrana NE

    更新日期:2018-01-01 00:00:00

  • Microbial production of dihydroxyacetone.

    abstract::Dihydroxyacetone is extensively used in cosmetic industry as an artificial suntan besides having clinical and biological applications. Thus, it is important to meet the commercial demand of dihydroxyacetone at an economical and qualitative level. Microbial route of production is found to be more favorable for dihydrox...

    journal_title:Biotechnology advances

    pub_type: 杂志文章,收录出版,评审

    doi:10.1016/j.biotechadv.2008.02.001

    authors: Mishra R,Jain SR,Kumar A

    更新日期:2008-07-01 00:00:00

  • Longer action means better drug: tuning up protein therapeutics.

    abstract::An increasing number of proteins are currently available on the market as therapeutics and this branch of the pharmaceutical industry will expand substantially during the coming years. As many diseases result from dysfunction of proteins forming multicomponent complexes, protein drugs with their inherent high specific...

    journal_title:Biotechnology advances

    pub_type: 杂志文章,评审

    doi:10.1016/j.biotechadv.2011.03.005

    authors: Szlachcic A,Zakrzewska M,Otlewski J

    更新日期:2011-07-01 00:00:00

  • Synthetic biology tools for engineering Yarrowia lipolytica.

    abstract::The non-conventional oleaginous yeast Yarrowia lipolytica shows great industrial promise. It naturally produces certain compounds of interest but can also artificially generate non-native metabolites, thanks to an engineering process made possible by the significant expansion of a dedicated genetic toolbox. In this re...

    journal_title:Biotechnology advances

    pub_type: 杂志文章,评审

    doi:10.1016/j.biotechadv.2018.10.004

    authors: Larroude M,Rossignol T,Nicaud JM,Ledesma-Amaro R

    更新日期:2018-12-01 00:00:00

  • Recent advances in the biosynthesis of penicillins, cephalosporins and clavams and its regulation.

    abstract::The beta-lactam antibiotics have been serving mankind for over 70 years. Despite this old age, they continue to provide health to the world population by virtue of industrial production and discoveries of new secondary metabolite molecules with useful activities. Sales of these remarkable compounds have reached over $...

    journal_title:Biotechnology advances

    pub_type: 杂志文章,评审

    doi:10.1016/j.biotechadv.2012.12.001

    authors: Ozcengiz G,Demain AL

    更新日期:2013-03-01 00:00:00

  • A review of high value-added molecules production by microalgae in light of the classification.

    abstract::This work reviews applications of high added value molecules produced from microalgae. Older forms of valorization - health food and quality feed, polyunsaturated fatty acids, pigments, carbohydrates - are currently penetrating their markets. They are driven by desirable properties: texturer and dye for food industry,...

    journal_title:Biotechnology advances

    pub_type: 杂志文章,评审

    doi:10.1016/j.biotechadv.2020.107545

    authors: Levasseur W,Perré P,Pozzobon V

    更新日期:2020-01-01 00:00:00

  • A continuous biological process to decolorize bleach plant effluents.

    abstract::Although almost every U.S. pulp mill has a biological wastewater treatment system, these systems based on bacteria, are largely ineffective in the removal of color. For this reason, we have attempted to utilize Phanerochaete chrysosporium, a fungus known to degrade lignin, as the primary organism in a novel waste trea...

    journal_title:Biotechnology advances

    pub_type: 杂志文章

    doi:10.1016/0734-9750(84)90010-7

    authors: Joyce TW,Chang H,Campbell AG Jr,Gerrard ED,Kirk TK

    更新日期:1984-01-01 00:00:00

  • Library preparation for next generation sequencing: A review of automation strategies.

    abstract::Next generation sequencing is in the process of evolving from a technology used for research purposes to one which is applied in clinical diagnostics. Recently introduced high throughput and benchtop instruments offer fully automated sequencing runs at a lower cost per base and faster assay times. In turn, the complex...

    journal_title:Biotechnology advances

    pub_type: 杂志文章,评审

    doi:10.1016/j.biotechadv.2020.107537

    authors: Hess JF,Kohl TA,Kotrová M,Rönsch K,Paprotka T,Mohr V,Hutzenlaub T,Brüggemann M,Zengerle R,Niemann S,Paust N

    更新日期:2020-01-01 00:00:00